The global epidemiology of vitiligo: A systematic review and meta-analysis of the incidence and prevalence

Morten Bahrt Haulrig, Rownaq Al-Sofi, Subisan Baskaran, Mie Siewertsen Bergmann, Marianne Løvendorf, Beatrice Dyring-Andersen, Lone Skov, Nikolai Loft
{"title":"The global epidemiology of vitiligo: A systematic review and meta-analysis of the incidence and prevalence","authors":"Morten Bahrt Haulrig,&nbsp;Rownaq Al-Sofi,&nbsp;Subisan Baskaran,&nbsp;Mie Siewertsen Bergmann,&nbsp;Marianne Løvendorf,&nbsp;Beatrice Dyring-Andersen,&nbsp;Lone Skov,&nbsp;Nikolai Loft","doi":"10.1002/jvc2.526","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n <p>Vitiligo is described with a prevalence of 0.5%−1%. Recent studies suggest an increasing prevalence, but there is a scarcity of studies that have systematically evaluated the global incidence and prevalence. We examined the incidence and the global, regional, and country-specific prevalence of vitiligo in the general population (PROSPERO: CRD42021261643). We systematically searched PubMed, EMBASE, and Web of Science. Each study was categorised in subgroups. The overall analysis comprised all studies, except for studies only examining children and adolescents. Pooled proportions were calculated with the DerSimonian-Laird method for random-effects models with 95% confidence intervals (CI). Of the 7,838 identified studies, 171 were eligible for analysis (participants <i>n</i> = 572,334,973). The overall incidence was 1.59 per 10,000 person-years (95% CI: 0.70−2.83). The overall prevalence was 0.40% (95% CI: 0.37−0.44); no difference was observed between females (0.50%, 95% CI: 0.36−0.66) and males (0.49%, 95% CI: 0.35−0.65). West Asia showed the highest prevalence (0.77%, 95% CI: 0.44−1.10) and East Asia the lowest (0.12%, 95% CI: 0.10−0.14). The highest country-specific prevalence was reported in Jordan (1.34%, 95% CI: 0.12−3.87) and the lowest in Sweden (0.19%, 95% CI: 0.08−0.34). Children and adolescents showed a lower prevalence (0.27%, 95% CI: 0.24−0.31) compared to adults (0.70%, 95% CI: 0.59−0.81). Questionnaire-based studies showed a higher prevalence (0.73%, 95% CI: 0.52−0.98) compared to examination-based studies (0.59%, 95% CI: 0.46−0.73) and register-based studies (0.13%, 95% CI: 0.10−0.17). The prevalence in examination-based studies increased from 0.40% (95% CI: 0.17−0.73) between 1943 and 1979 to 0.89% (95% CI: 0.68−1.13) between 2020 and 2023. Questionnaire-based studies also showed an increasing prevalence, while in register-based studies, the prevalence was continuously low. This study shows the global impact of vitiligo and how subgroup analyses influence the prevalence. The overall prevalence of vitiligo is lower than previously assumed; females and males are equally affected, and vitiligo is more common in adults.</p>\n </section>\n </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 5","pages":"1410-1419"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.526","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Vitiligo is described with a prevalence of 0.5%−1%. Recent studies suggest an increasing prevalence, but there is a scarcity of studies that have systematically evaluated the global incidence and prevalence. We examined the incidence and the global, regional, and country-specific prevalence of vitiligo in the general population (PROSPERO: CRD42021261643). We systematically searched PubMed, EMBASE, and Web of Science. Each study was categorised in subgroups. The overall analysis comprised all studies, except for studies only examining children and adolescents. Pooled proportions were calculated with the DerSimonian-Laird method for random-effects models with 95% confidence intervals (CI). Of the 7,838 identified studies, 171 were eligible for analysis (participants n = 572,334,973). The overall incidence was 1.59 per 10,000 person-years (95% CI: 0.70−2.83). The overall prevalence was 0.40% (95% CI: 0.37−0.44); no difference was observed between females (0.50%, 95% CI: 0.36−0.66) and males (0.49%, 95% CI: 0.35−0.65). West Asia showed the highest prevalence (0.77%, 95% CI: 0.44−1.10) and East Asia the lowest (0.12%, 95% CI: 0.10−0.14). The highest country-specific prevalence was reported in Jordan (1.34%, 95% CI: 0.12−3.87) and the lowest in Sweden (0.19%, 95% CI: 0.08−0.34). Children and adolescents showed a lower prevalence (0.27%, 95% CI: 0.24−0.31) compared to adults (0.70%, 95% CI: 0.59−0.81). Questionnaire-based studies showed a higher prevalence (0.73%, 95% CI: 0.52−0.98) compared to examination-based studies (0.59%, 95% CI: 0.46−0.73) and register-based studies (0.13%, 95% CI: 0.10−0.17). The prevalence in examination-based studies increased from 0.40% (95% CI: 0.17−0.73) between 1943 and 1979 to 0.89% (95% CI: 0.68−1.13) between 2020 and 2023. Questionnaire-based studies also showed an increasing prevalence, while in register-based studies, the prevalence was continuously low. This study shows the global impact of vitiligo and how subgroup analyses influence the prevalence. The overall prevalence of vitiligo is lower than previously assumed; females and males are equally affected, and vitiligo is more common in adults.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
白癜风的全球流行病学:发病率和患病率的系统回顾和荟萃分析
白癜风的患病率为0.5% - 1%。最近的研究表明,患病率正在上升,但缺乏系统评估全球发病率和患病率的研究。我们研究了白癜风在普通人群中的发病率和全球、区域和国家特定患病率(PROSPERO: CRD42021261643)。我们系统地检索了PubMed, EMBASE和Web of Science。每项研究都被分成亚组。总体分析包括所有研究,除了仅针对儿童和青少年的研究。随机效应模型采用dersimonan - laird方法计算合并比例,置信区间为95%。在7838项确定的研究中,171项符合分析条件(参与者n = 572,334,973)。总发病率为1.59 / 10000人年(95% CI: 0.70 ~ 2.83)。总患病率为0.40% (95% CI: 0.37 ~ 0.44);女性(0.50%,95% CI: 0.36 ~ 0.66)和男性(0.49%,95% CI: 0.35 ~ 0.65)之间无差异。西亚发病率最高(0.77%,95% CI: 0.44 ~ 1.10),东亚发病率最低(0.12%,95% CI: 0.10 ~ 0.14)。约旦的国家特异性患病率最高(1.34%,95% CI: 0.12 - 3.87),瑞典最低(0.19%,95% CI: 0.08 - 0.34)。儿童和青少年的患病率(0.27%,95% CI: 0.24 ~ 0.31)低于成人(0.70%,95% CI: 0.59 ~ 0.81)。与基于检查的研究(0.59%,95% CI: 0.46 - 0.73)和基于登记的研究(0.13%,95% CI: 0.10 - 0.17)相比,基于问卷的研究显示更高的患病率(0.73%,95% CI: 0.52 - 0.98)。在基于检查的研究中,患病率从1943年至1979年的0.40% (95% CI: 0.17 ~ 0.73)增加到2020年至2023年的0.89% (95% CI: 0.68 ~ 1.13)。基于问卷调查的研究也显示患病率在增加,而基于登记的研究中,患病率一直很低。这项研究显示了白癜风的全球影响以及亚组分析如何影响患病率。白癜风的总体患病率低于先前的假设;女性和男性同样受到影响,白癜风在成年人中更为常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
0
期刊最新文献
Issue Information A reply to “Letter to the editor in response to the article ‘To assess the attitudes of Irish patients attending a pigmented lesion clinic and healthcare staff employed in an academic hospital to biobanking, a quantitative study’” Letter to the editor in response to the article “To assess the attitudes of Irish patients attending a pigmented lesion clinic and healthcare staff employed in an academic hospital to biobanking, a quantitative study” The impact of alopecia areata on patients' daily lives: A study using social media in France HIV-negative HHV8-positive multicentric Castleman's disease coexistent with atypical Kaposi's sarcoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1